Alpha lipoic acid for kids on dialysis
Treatments studied
Part of Heart & circulation, Kidney & urinary clinical trials.
This trial tests if alpha lipoic acid, a common supplement, can help reduce stress on the body for children who are on regular hemodialysis. It may offer a way to support their health during treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child is 18 years old or younger and goes to dialysis regularly.
- Your child can swallow capsules (pills).
- Your child does not have severe heart failure.
- Your child does not have an active inflammatory condition (like a bad infection or autoimmune disease).
- Your child is not already taking supplements that lower oxidative stress or inflammation.
- Your child is not allergic to alpha lipoic acid.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether taking alpha lipoic acid (an antioxidant) alongside the antibiotic colistin can help protect the kidneys from damage. It may be helpful for patients who need colistin to fight a serious bacterial infection.
This study tests whether a supplement called alpha-lipoic acid can help protect your kidneys from damage caused by cisplatin, a common chemotherapy drug. If it works, it could reduce side effects and help you tolerate your cancer treatment better.
This trial tests if a medication can protect the liver during chemotherapy for children and teenagers newly diagnosed with acute lymphoblastic leukemia (ALL). It aims to reduce liver damage caused by treatment.
This trial tests whether lipoic acid can help people with long-term heart failure. It may improve how well your heart works. The study lasts for a period of time and you will take the study medicine or a placebo (a pill with no active ingredient).
This trial tests whether a medicine called spironolactone can help children on hemodialysis who still have anemia despite usual treatment. It aims to see if this drug improves red blood cell production better than standard care alone.
This study tests whether propionic acid can help the immune system work differently in children with advanced chronic kidney disease who receive regular dialysis. It may help regulate immune cells, aiming for better immune function while keeping you medically stable.
Hear when a new Hemodialysis Complication trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.